NCT06733363
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Clinical trial condition
Recurrent Bladder Carcinoma
Explore clinical trials studying Recurrent Bladder Carcinoma. Study availability and eligibility vary by location and protocol.
12 public trials
2 recruiting studies
Recurrent Bladder Carcinoma trial results
NCT01050504
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +24 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01638533
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT02808143
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +12 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT03229278
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Completed
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
NCT02437370
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +19 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT00118040
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- South Orange County Surgical Medical Group Inc Laguna Hills, California, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- AccuMed Research Associates Garden City, New York, United States
Completed
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
NCT02646319
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Malignant Neoplasm, +73 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
Completed
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
NCT01938573
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +12 more
- Locations
-
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States